Cell Therapy with Human IL-10-Producing ILC2s Enhances Islet Function and Inhibits Allograft Rejection

Investigators explored whether group 2 innate lymphoid cells (ILC2s) that produce IL-10 could enhance islet function and prevent allograft rejection in humanized mouse models of islet transplantation.